ERA Media Release - Mr Mohamed Ramadan

The ERA Stewards opened an inquiry on Thursday 27th May 2021, into the notification by the Dubai Equine Forensic Unit (EFU) that the prohibited substance Orphenadrine had been detected in the post-race urine sample taken from GANESH D’AILLAS (FR), after it raced in Race 3 “Al Masoudi Handicap” over 1000m at Al Ain Racecourse on the 28th February 2020.

Evidence was taken from Mr. Mohamed Ramadan (Trainer of GANESH D’AILLAS (FR)), Dr. Kieran Finn (ERA Regulatory Veterinarian) and Dr. Michael Subhahar (Chief Analyst – EFU). The following matters were established during the inquiry;
1. On Sunday 8th March 2020, the ERA Stewards were advised of the irregularity to Orphenadrine in respect to the post-race urine sample taken from GANESH D’AILLAS (FR).
2. On Wednesday 11th March 2020, Mr. M Ramadan was notified of the irregularity in the sample taken from GANESH D’AILLAS (FR) via an official stable visit at his Al Ain Equestrian Club Stables. Mr. M Ramadan stated that GANESH D’AILLAS (FR) was treated with BATACAS a product by Chinfield, on Sunday 23rd February 2020, which contains the active ingredient Orphenadrine. Mr. M Ramadan further stated that his stable veterinarian had failed to log the treatment of BATACAS into his medical log book for GANESH D’AILLAS (FR).
3. During the stable visit, Mr. M Ramadan advised that he wished to exercise his right to have the reserve portion of the sample analysed by another accredited racing laboratory in accordance with ERA Rule 95D(ii).
4. On Tuesday 24th March 2020, the ERA Stewards received confirmation from the Hong Kong Jockey Club laboratory, that the presence of Orphenadrine was detected in the “B” urine sample from GANESH D’AILLAS (FR).
5. Evidence was tendered by Dr. K Finn that Orphenadrine is considered to be a therapeutic substance, however would have performance altering effects. It is used to assist in alleviating muscle spasms and when present in a race-day sample is considered to be a prohibited substance under the ERA Rules of Racing. Although the ERA do not publish a recommended withdrawal time for Orphenadrine, if requested it would be recommended to allow 7 clear days before racing.
6. Evidence was tendered by Dr. M Subhahar that the sample provide by GANESH D’AILLAS (FR) returned low levels of Orphenadrine.
7. Mr. M Ramadan advised that the ERA did not have recommended withdrawal time for Orphenadrine and acknowledged that prior to using the product he should have sought further information from the ERA.

Trainer Mr. M Ramadan pled guilty to a charge under the provisions of ERA Rule 95AAA 1(b), in that as a licenced Trainer, he administered or caused to be administered “Orphenadrine” to GANESH D’AILLAS (FR) prior to race 3 “Al Masoudi Handicap” over 1000 metres at Al Ain Racecourse on Firday 28th of February 2020, with the post-race urine sample taken from GANESH D’AILLAS (FR), detecting the prohibited substance Orphenadrine.

In determining the appropriate penalty in this case, the Stewards considered a number of factors including:
• The circumstances of the offence;
• The nature of the prohibited substance detected, that being a therapeutic substance;
• The treatment was given under veterinary advise;
• General and specific deterrence;
• The integrity and image of racing in the UAE;
• Mr. M Ramadan’s forthright evidence and co-operation throughout the inquiry;
• Mr. M Ramadan’s guilty plea and record in relation to the prohibited substance rules (see below).

Mr. M Ramadan was fined the sum of AED 40,000.

Further Mr. M Ramadan pled guilty to a charge under the provisions of ERA Rule 31B(iv), in that he failed to maintain the Medication Log Book for GANESH D’AILLAS (FR). Mr. M Ramadan was fined the sum of AED 5,000.

Pursuant to ERA 86(ii), GANESH D’AILLAS (FR) was disqualified from 13th place in Race 3, “Al Masoudi Handicap” over 1000m at Al Ain Racecourse on the 28th February 2020 and the placings were adjusted accordingly.

Mr. M Ramadan was advised of his rights of appeal.

Mr. M Ramadan’s record in relation to prohibited substance:
• No prior breaches.

Relevant Rules:
ERA Rules 31B(iv) – Trainers who fail to maintain medical records or cannot produce the aforementioned records are guilty of an Offence.

ERA 86(ii) – Where any declared runner has been the subject of an examination under the Rules 8(vi) and or (vii) and has been found to have received a Prohibited Substances, the Horse shall be disqualified from the Race and from other Races as the ERA determines.
ERA Rule 95AAA 1. (b) – Any Person shall be liable to Penalty if; they administer or cause to be administered any Prohibited Substance which is detected in any Sample taken pursuant to Rule 8(vii) from any Horse prior to or following any Race, or Test.

ERA Rules 95D(ii) – Upon the detection by an Accredited Racing Laboratory of a Prohibited Substance in the Sample from a Horse, such laboratory shall notify its finding to the Stewards, who shall then notify the Trainer of the Horse of such finding and give him the option to have the reserve portion of the Sample Tested at another ERA-approved Accredited Racing Laboratory. The Trainer will have 3 days to notify the Stewards of such requirement. A refusal by the Trainer to Test the reserve portion of the Sample shall not prevent the Stewards from having the reserve portion of the Sample Tested.

Stewards Panel:
• Mr. Sam Shinsky (Chairman), Mr. Taylor Wilson and Mr. Ajay Anne.